GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Retail - Defensive » X Bioscience PCL (BKK:XBIO-W7) » Definitions » EV-to-Revenue

X Bioscience PCL (BKK:XBIO-W7) EV-to-Revenue : 3.14 (As of Jul. 21, 2025)


View and export this data going back to 2025. Start your Free Trial

What is X Bioscience PCL EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, X Bioscience PCL's enterprise value is ฿961.8 Mil. X Bioscience PCL's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was ฿305.9 Mil. Therefore, X Bioscience PCL's EV-to-Revenue for today is 3.14.

The historical rank and industry rank for X Bioscience PCL's EV-to-Revenue or its related term are showing as below:

BKK:XBIO-W7' s EV-to-Revenue Range Over the Past 10 Years
Min: -1.94   Med: 3.28   Max: 131.23
Current: 3.08

During the past 13 years, the highest EV-to-Revenue of X Bioscience PCL was 131.23. The lowest was -1.94. And the median was 3.28.

BKK:XBIO-W7's EV-to-Revenue is ranked worse than
92.01% of 313 companies
in the Retail - Defensive industry
Industry Median: 0.67 vs BKK:XBIO-W7: 3.08

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-07-21), X Bioscience PCL's stock price is ฿0.02. X Bioscience PCL's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was ฿0.34. Therefore, X Bioscience PCL's PS Ratio for today is 0.06.


X Bioscience PCL EV-to-Revenue Historical Data

The historical data trend for X Bioscience PCL's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

X Bioscience PCL EV-to-Revenue Chart

X Bioscience PCL Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.31 15.64 6.00 3.59 5.29

X Bioscience PCL Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.91 4.21 4.00 5.29 2.74

Competitive Comparison of X Bioscience PCL's EV-to-Revenue

For the Food Distribution subindustry, X Bioscience PCL's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


X Bioscience PCL's EV-to-Revenue Distribution in the Retail - Defensive Industry

For the Retail - Defensive industry and Consumer Defensive sector, X Bioscience PCL's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where X Bioscience PCL's EV-to-Revenue falls into.


;
;

X Bioscience PCL EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

X Bioscience PCL's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=961.835/305.853
=3.14

X Bioscience PCL's current Enterprise Value is ฿961.8 Mil.
X Bioscience PCL's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿305.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


X Bioscience PCL  (BKK:XBIO-W7) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

X Bioscience PCL's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.02/0.343
=0.06

X Bioscience PCL's share price for today is ฿0.02.
X Bioscience PCL's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.34.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


X Bioscience PCL EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of X Bioscience PCL's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


X Bioscience PCL Business Description

Traded in Other Exchanges
Address
Phahon Yothin Road, No.304, Room No.1803-1806, 18th Floor, Vanit Place Aree Tower (Tower A, Sam Sen Nai, Bangkok, THA, 10400
X Bioscience PCL is engaged in investment in food and beverages business and the group are engaged in selling food and beverages, and manufacturing and selling biological products. The group operates in two business segments: the food and beverage sales segment and the internal management services segment provided by the parent company. The group operates in a single geographic area, which is Thailand. The company's brand consists of Kagonaya, Bake, and Leboeuf.

X Bioscience PCL Headlines

No Headlines